Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Heterocyclic Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112939971A discloses pyrido[2,3-d]pyrimidin-7-one derivatives as potent NEDD8 inhibitors, offering new routes for cost-effective API manufacturing and supply chain stability.
Patent CN102311439B reveals novel synthesis for high-purity diazabicyclo intermediates. Enhance solubility and reduce API manufacturing costs with scalable routes.
Novel patent CN104447523B enables efficient aminopyridine production from pyridine mixtures, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108395408B details a scalable route for [4-(1,1-difluoro-ethyl)-pyrimidine]-5-methanamine. Achieve cost reduction in API manufacturing with this efficient aqueous reduction strategy.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.